Sign In
Buy PFS
$23.38
+0.370 (+1.61%)
At Close: Jun 23, 2026
Provident Bank Appoints Adriano Duarte EVP and Chief Financial Officer
08:00am, Tuesday, 23'rd Jun 2026
ISELIN, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, announced today the appointment of Adriano Duarte to Executive Vice President and Chie
AbbVie Announces European Commission Approval of SKYRIZIÂ (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaqu
Tunkillia Pre-Feasibility Study Begins
09:00pm, Sunday, 21'st Jun 2026
Expanded programs targeting Q1 CY27 completion & ML application HIGHLIGHTS GR Engineering appointed to lead Pre-feasibility Study (PFS) for Tunkillia Gold Project; targeting Q1 CY27 PFS completion to
Provident Bank Announces $1 Million in Grants to Ten New Jersey Non-Profit Organizations
08:00am, Wednesday, 17'th Jun 2026
Funds will be used to support revitalization plans for distressed neighborhoods Funds will be used to support revitalization plans for distressed neighborhoods
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously
New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combi
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
08:00am, Thursday, 11'th Jun 2026
[url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 datas
REGN Investors Have Opportunity to Join Regeneron Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
04:00pm, Wednesday, 10'th Jun 2026
[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron P
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
11:00pm, Thursday, 04'th Jun 2026
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility PR Newswire SINGAPORE,
Provident Bank Names Annamaria Vitelli EVP, Chief Wealth Officer and President of Beacon Trust
08:00am, Thursday, 04'th Jun 2026
Seasoned Wealth Management Executive to Lead Strategic Growth of Provident Bank's Wealth Management Business Seasoned Wealth Management Executive to Lead Strategic Growth of Provident Bank's Wealth Ma
Further positive results from the Phase III SERENA-6 trial showed AstraZeneca's camizestrant plus a cyclin-dependent kinase (CDK) 4/6 inhibitor â palbociclib
IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Li
Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types
02:00am, Monday, 01'st Jun 2026
Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types PR Newswi
